HOME_PAGE_HEADER_CONTENT

A female patient and a female physician, representing different ethnicities in conversation A female patient and a female physician, representing different ethnicities in conversation

Passion for Innovation.

Compassion for Patients.

Learn More-HP Updated

Learn More

Man and woman embracing
 
Knowledge is Power – The Importance of Biomarker Testing and Learning From Each Other

Breast Cancer Awareness Month (BCAM) is synonymous with education and exchanging information about the disease, its impact and ways to detect and manage it. The month is an important time to help peop read more

A female scientist wearing a hairnet, mask, eyewear and a blue glove is holding a red test tube
 
COVID-19 Statement

Daiichi Sankyo, Inc. has taken measures to contribute to the overall effort to limit the spread of the virus that causes COVID-19. read more

Featured News

Press Releases

Email Alert
October 25, 2021 NEW Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer Press release PDF download iconDownload
October 04, 2021 NEW ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Patients with HER2 Positive Metastatic Breast Cancer Treated with One or More Prior Anti-HER2-Based Regimens Press release PDF download iconDownload
September 19, 2021 Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations Press release PDF download iconDownload
September 18, 2021 ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer Press release PDF download iconDownload
View All